Asensus Surgical, Inc

Asensus Surgical, Inc. is a medical device company specializing in robotic-assisted surgical systems and augmented intelligence solutions for the operating room. The company manufactures the Senhance® Surgical System, a robotic platform designed to provide surgeons with enhanced control, precision, and real-time decision support during minimally invasive procedures. The Senhance system features an innovative open ergonomic design that improves surgeon communication and physical comfort while maintaining intra-operative control. A cornerstone of Asensus's technology is the Intelligent Surgical Unit™ (ISU™), an intra-operative augmented intelligence system approved globally that delivers real-time surgical insights to enhance decision-making, reduce variability, and improve procedural outcomes. The ISU represents the company's Performance-Guided Surgery™ platform, which layers advanced robotics with reusable 3mm and 5mm articulating surgical instruments to extend safer, more predictable surgical care beyond traditional robotic-assisted surgery models. Asensus markets its systems to hospital operating rooms, surgical centers, and healthcare institutions globally, targeting surgeons seeking to perform safer, more accessible robotic-assisted procedures. The company has received multiple industry recognitions including Digital Health Awards and Surgical Robotics Industry Award nominations. While specific FDA 510(k) status and detailed regulatory certifications are not explicitly stated in available content, the site indicates the ISU is approved for use globally, suggesting appropriate regulatory clearances. The company is headquartered in Durham, North Carolina, and maintains an international team of physician partners and clinical collaborators.